Anemia [clinicaltrials_resource:fc45c680042272ad16c9a1b778a8a14c]
Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection [clinicaltrials:NCT00000587]Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine [clinicaltrials:NCT00001533]Screening for Hematology Branch Protocols [clinicaltrials:NCT00001620]clinicaltrials:NCT00003138Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy [clinicaltrials:NCT00003341]Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003398]clinicaltrials:NCT00003600Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003681]Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00004215]Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue [clinicaltrials:NCT00004914]Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer [clinicaltrials:NCT00004917]Anemia and Surgery: Indications For Transfusion [clinicaltrials:NCT00005308]Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia [clinicaltrials:NCT00017004]Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer [clinicaltrials:NCT00022386]clinicaltrials:NCT00031980Chemotherapy Related Anemia [clinicaltrials:NCT00035607]Anemia in Patients With a Non-Myeloid Malignancy [clinicaltrials:NCT00038064]Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia? [clinicaltrials:NCT00039884]Epoetin Beta in Treating Anemia in Patients With Cervical Cancer [clinicaltrials:NCT00046969]A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia [clinicaltrials:NCT00048035]A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis. [clinicaltrials:NCT00048048]Heart Failure and Anemia [clinicaltrials:NCT00049985]Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00053001]clinicaltrials:NCT00058331Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer [clinicaltrials:NCT00060398]clinicaltrials:NCT00070382clinicaltrials:NCT00071032Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00072059]clinicaltrials:NCT00077311A Study of Mircera for the Treatment of Anemia in Dialysis Patients [clinicaltrials:NCT00077597]A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients [clinicaltrials:NCT00077610]A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. [clinicaltrials:NCT00077623]A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. [clinicaltrials:NCT00077766]A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis [clinicaltrials:NCT00081471]A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients [clinicaltrials:NCT00081484]Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy [clinicaltrials:NCT00083434]Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy [clinicaltrials:NCT00083486]Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia [clinicaltrials:NCT00086086]clinicaltrials:NCT00090753Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer [clinicaltrials:NCT00091858]
condition [clinicaltrials_vocabulary:condition]
Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH) [clinicaltrials:NCT00000586]Cord Blood Stem Cell Transplantation Study (COBLT) [clinicaltrials:NCT00000603]Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) [clinicaltrials:NCT00000623]Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia [clinicaltrials:NCT00001197]Stem Cell Factor Medication for Aplastic Anemia [clinicaltrials:NCT00001398]Gene Therapy for the Treatment of Fanconi's Anemia Type C [clinicaltrials:NCT00001399]clinicaltrials:NCT00001626Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes [clinicaltrials:NCT00001627]Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia [clinicaltrials:NCT00001716]Medical Treatment for Diamond Blackfan Anemia [clinicaltrials:NCT00001749]clinicaltrials:NCT00001962clinicaltrials:NCT00001964Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002798]Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy [clinicaltrials:NCT00003341]clinicaltrials:NCT00004143Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia [clinicaltrials:NCT00004323]Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria [clinicaltrials:NCT00004464]Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00004474]Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia [clinicaltrials:NCT00004492]Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue [clinicaltrials:NCT00004914]PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [clinicaltrials:NCT00005064]Tipifarnib in Treating Patients With Myelodysplastic Syndromes [clinicaltrials:NCT00005845]Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconi's Anemia [clinicaltrials:NCT00005891]Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia [clinicaltrials:NCT00005892]Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia [clinicaltrials:NCT00005896]Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia [clinicaltrials:NCT00005935]Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy [clinicaltrials:NCT00005942]Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia [clinicaltrials:NCT00006127]BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia [clinicaltrials:NCT00006213]Oral Manifestations of Aplastic Anemia [clinicaltrials:NCT00006300]clinicaltrials:NCT00006400Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [clinicaltrials:NCT00008177]Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia [clinicaltrials:NCT00011505]Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia [clinicaltrials:NCT00011648]Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission [clinicaltrials:NCT00011830]Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [clinicaltrials:NCT00012376]Thalidomide in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00015990]Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00017654]Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer [clinicaltrials:NCT00022386]Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00027820]
condition browse [clinicaltrials_vocabulary:condition-browse]
Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH) [clinicaltrials:NCT00000586]Cord Blood Stem Cell Transplantation Study (COBLT) [clinicaltrials:NCT00000603]Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) [clinicaltrials:NCT00000623]Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia [clinicaltrials:NCT00001197]Stem Cell Factor Medication for Aplastic Anemia [clinicaltrials:NCT00001398]Gene Therapy for the Treatment of Fanconi's Anemia Type C [clinicaltrials:NCT00001399]clinicaltrials:NCT00001626Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes [clinicaltrials:NCT00001627]Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia [clinicaltrials:NCT00001716]Medical Treatment for Diamond Blackfan Anemia [clinicaltrials:NCT00001749]clinicaltrials:NCT00001962clinicaltrials:NCT00001964Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002798]Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy [clinicaltrials:NCT00003341]clinicaltrials:NCT00004143Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia [clinicaltrials:NCT00004323]Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria [clinicaltrials:NCT00004464]Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00004474]Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell Anemia [clinicaltrials:NCT00004492]Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related Fatigue [clinicaltrials:NCT00004914]PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome [clinicaltrials:NCT00005064]Tipifarnib in Treating Patients With Myelodysplastic Syndromes [clinicaltrials:NCT00005845]Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconi's Anemia [clinicaltrials:NCT00005891]Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia [clinicaltrials:NCT00005892]Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia [clinicaltrials:NCT00005896]Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia [clinicaltrials:NCT00005935]Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy [clinicaltrials:NCT00005942]Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia [clinicaltrials:NCT00006127]BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia [clinicaltrials:NCT00006213]Oral Manifestations of Aplastic Anemia [clinicaltrials:NCT00006300]clinicaltrials:NCT00006400Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [clinicaltrials:NCT00008177]Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia [clinicaltrials:NCT00011505]Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia [clinicaltrials:NCT00011648]Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission [clinicaltrials:NCT00011830]Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer [clinicaltrials:NCT00012376]Thalidomide in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00015990]Study of Allogeneic Bone Marrow and T-Cell Depleted, CD34+ Peripheral Blood Stem Cell Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00017654]Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer [clinicaltrials:NCT00022386]Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00027820]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
eligibility for clinicaltrials:NCT00978575 [clinicaltrials_resource:19311037e8c4baf2520766e520db6b1e]eligibility for clinicaltrials:NCT02383641 [clinicaltrials_resource:1c087f1056b09309a0c2e95700fbbb63]eligibility for clinicaltrials:NCT00199277 [clinicaltrials_resource:355ccd28a1ac00219da7169679a90795]eligibility for clinicaltrials:NCT01215344 [clinicaltrials_resource:85fc9000f393241a665dc28c9a6d6992]eligibility for clinicaltrials:NCT00358150 [clinicaltrials_resource:ddad608fc27f88c84fa5f494558e8606]eligibility for clinicaltrials:NCT01637870 [clinicaltrials_resource:f03d01e7997d7917a1d8966d2c90e71a]eligibility for clinicaltrials:NCT01078441 [clinicaltrials_resource:f96dc1c092487a942de882d8a92b09bf]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT00307190 [clinicaltrials_resource:07efdc45c56e13ad1906bb374fd06dce]eligibility for clinicaltrials:NCT01048268 [clinicaltrials_resource:17b05cf20685944e8892734b1844e91c]eligibility for clinicaltrials:NCT00978575 [clinicaltrials_resource:19311037e8c4baf2520766e520db6b1e]eligibility for clinicaltrials:NCT02383641 [clinicaltrials_resource:1c087f1056b09309a0c2e95700fbbb63]eligibility for clinicaltrials:NCT00199277 [clinicaltrials_resource:355ccd28a1ac00219da7169679a90795]eligibility for clinicaltrials:NCT01215344 [clinicaltrials_resource:85fc9000f393241a665dc28c9a6d6992]eligibility for clinicaltrials:NCT00358150 [clinicaltrials_resource:ddad608fc27f88c84fa5f494558e8606]eligibility for clinicaltrials:NCT01519830 [clinicaltrials_resource:eb04ea7e8115e979d18365fc7196255c]eligibility for clinicaltrials:NCT00030381 [clinicaltrials_resource:ee0cf78854594dd8a2dbe9a703a9717a]eligibility for clinicaltrials:NCT01637870 [clinicaltrials_resource:f03d01e7997d7917a1d8966d2c90e71a]eligibility for clinicaltrials:NCT01078441 [clinicaltrials_resource:f96dc1c092487a942de882d8a92b09bf]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Anemia [clinicaltrials_resource:fc45c680042272ad16c9a1b778a8a14c]
Bio2RDF identifier
fc45c680042272ad16c9a1b778a8a14c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:fc45c680042272ad16c9a1b778a8a14c
identifier
clinicaltrials_resource:fc45c680042272ad16c9a1b778a8a14c
title
Anemia
@en
type
label
Anemia [clinicaltrials_resource:fc45c680042272ad16c9a1b778a8a14c]
@en